📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-09-16 17:45
0 analysed today
FollowTelegram
0
Today
152,076
All-time analysed
43,619
Positive
6,746
Negative
92,864
Neutral
8,779
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
8 announcements match the current filters (relevance ≥ 5).
KRM Ayurveda Opens 2,100 Sq. Ft. Day Care Center in Navi Mumbai on 5-Year Lease
KRM Ayurveda Limited has established a new day care center under the 'Karma Ayurveda' unit in Vashi, Navi Mumbai, Maharashtra. The facility spans 2,100 sq. ft. and has been secured on a lease period of 5 years. Operations at the center commenced on 03 September 2026. Financial metrics such as capex, expected revenue contribution, and lease rental amounts were not disclosed in the filing.
Confidence: HIGH
What changedKRM Ayurveda expanded its operational footprint into Maharashtra with a new 2,100 sq. ft. day care center in Navi Mumbai.
Why it mattersThe center marks a physical footprint expansion that could incrementally add to patient outreach and operational revenue, though exact financials remain undisclosed.
Area: 2100 sq. ft.Lease Period: 5 yearsCommencement Date: 03 September, 2026
📅 Short termOperational rollout is already effective as of 03 September 2026; immediate revenue impact will likely be visible starting in upcoming quarterly reporting cycles.
📈 Long termExpands geographic presence in Western India over the 5-year lease tenure, supporting multi-city healthcare network growth.
⚠ Risk flags
- Financial investment, lease liabilities, and expected returns were not disclosed
Key Highlights
Established new center covering 2100 sq. ft. in Sector-17, Vashi, Navi Mumbai
Secured the premises on a lease period of 5 years
Commencement of operations effective 03 September 2026
Operating under the unit name 'Karma Ayurveda'
👀 What to Watch
Track subsequent quarterly results to gauge footfall, operational traction, and incremental revenue generated from this new Mumbai center.
KRM Ayurveda Establishes 2,100 Sq. Ft. Day Care Center in Navi Mumbai
KRM Ayurveda Limited has established a new day care center on a lease basis at Vashi, Navi Mumbai under the name 'Karma Ayurveda'. The facility covers an area of 2,100 sq. ft. and has a lease period of 5 years. The center commenced operations retroactively on September 3, 2026. Financial metrics regarding capital expenditure and expected revenue generation from this center were not disclosed.
Confidence: HIGH
What changedKRM Ayurveda opened a new leased day care center in Navi Mumbai operating under the 'Karma Ayurveda' brand.
Why it mattersThe new facility expands the company's clinical footprint into the Maharashtra market, supporting geographic revenue diversification.
Facility Area: 2100 sq. ft.Lease Period: 5 yearsCommencement Date: 03rd September, 2026
📅 Short termOperational commencement is already in effect; immediate stock price impact is expected to be minimal given the modest footprint.
📈 Long termServes as an indicator of branch-level expansion in metropolitan centers, though long-term impact depends on unit economics and scaling cadence.
⚠ Risk flags
- Lease commitment costs over a 5-year period
- Capital expenditure and revenue projections not disclosed
Key Highlights
Facility area spans 2,100 sq. ft.
Lease tenure established for 5 years
Commencement date of day care center was 03rd September, 2026
Located at Sector-17, Vashi, Navi Mumbai
👀 What to Watch
Track subsequent quarterly financial updates to assess incremental revenue contributions and operating costs associated with this center.
KRM Ayurveda Appoints Sachin Kumar Sharma as CFO Effective September 7, 2026
KRM Ayurveda Limited has appointed Sachin Kumar Sharma as its Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), effective September 7, 2026. Mr. Sharma holds around 12 years of experience in finance, accounting, financial reporting, audit, and regulatory compliance. The appointment was made in compliance with Regulation 30 of the SEBI LODR Regulations.
Confidence: HIGH
What changedSachin Kumar Sharma has been designated as the new Chief Financial Officer of KRM Ayurveda Limited.
Why it mattersThe CFO is a Key Managerial Personnel responsible for financial reporting, capital allocation, audit coordination, and statutory compliance.
Effective date of appointment: September 07, 2026Professional experience: around 12 years
📅 Short termRoutine executive appointment with no immediate financial or operational disruption expected.
📈 Long termEnsures continuity in statutory financial reporting, audit closures, and internal financial controls.
Key Highlights
Sachin Kumar Sharma appointed as Chief Financial Officer effective September 7, 2026
Appointee brings around 12 years of experience in corporate finance, audit, and controllership
Consent letter submitted under Section 203 & 2(51) of the Companies Act, 2013 on September 3, 2026
👀 What to Watch
Track the upcoming quarterly financial statements and disclosures to monitor financial governance and reporting under the new CFO.
KRM Ayurveda Announces CFO Transition and Schedules 7th AGM for September 30, 2026
KRM Ayurveda Limited announced the resignation of Chief Financial Officer Mr. Avtar Singh Rana, effective September 6, 2026. The Board has appointed Mr. Sachin Kumar Sharma as the new CFO effective September 7, 2026. Additionally, the company's 7th Annual General Meeting is scheduled for September 30, 2026, with a voting cut-off date of September 23, 2026. The Board also approved the Directors' Report for FY26 and appointed M/s Amit K Mangla & Company as the Secretarial Auditor for FY 2026-2027.
Confidence: HIGH
What changedKRM Ayurveda is replacing its Chief Financial Officer and setting dates/procedures for its 7th AGM.
Why it mattersThe CFO is a Key Managerial Personnel (KMP) responsible for financial governance and reporting; a seamless handover is crucial for financial operational continuity.
AGM Date: September 30, 2026E-voting Cut-off Date: September 23, 2026Outgoing CFO Resignation Date: September 06, 2026Incoming CFO Appointment Date: September 07, 2026
📅 Short termRoutine AGM proceedings and planned leadership transition in the finance department over the coming weeks.
📈 Long termLimited operational impact, provided governance and financial reporting continuity are maintained under the new CFO.
⚠ Risk flags
- KMP transition risk during annual reporting and AGM season
Key Highlights
CFO Mr. Avtar Singh Rana resigned effective September 6, 2026
Mr. Sachin Kumar Sharma appointed as Chief Financial Officer effective September 7, 2026
7th Annual General Meeting scheduled for September 30, 2026 at 12:30 PM IST via VC/OAVM
Cut-off date for e-voting eligibility set for September 23, 2026
👀 What to Watch
Track the smooth transition in the finance function under the incoming CFO and review the upcoming Annual Report ahead of the AGM on September 30, 2026.
KRM Ayurveda CFO Avtar Singh Rana Resigns Effective September 6, 2026
KRM Ayurveda Limited has announced the resignation of its Chief Financial Officer (KMP), Mr. Avtar Singh Rana. The resignation was tendered on August 31, 2026, citing personal reasons, and will take effect from September 6, 2026. The outgoing CFO confirmed that there are no other material reasons for his departure.
Confidence: HIGH
What changedMr. Avtar Singh Rana has stepped down from the post of Chief Financial Officer (CFO).
Why it mattersThe CFO is a Key Managerial Personnel (KMP) responsible for financial reporting and capital allocation; smooth transition to a successor is key.
Resignation date: 31st August, 2026Effective cessation date: 06th September, 2026
📅 Short termInterim administrative transition until a replacement CFO is appointed by the Board.
📈 Long termLimited, provided the company executes a prompt and orderly succession for the finance leadership.
⚠ Risk flags
- Key managerial personnel turnover
Key Highlights
Resignation tendered by CFO Mr. Avtar Singh Rana on August 31, 2026
Effective date of cessation is September 6, 2026
Reason cited as personal reasons with confirmation of no other material reasons
👀 What to Watch
Track subsequent exchange filings for the appointment of a new Chief Financial Officer to oversee financial reporting and operations.
KRM Ayurveda CFO Avtar Singh Rana Resigns Effective September 6, 2026
KRM Ayurveda Limited has announced the resignation of its Chief Financial Officer, Mr. Avtar Singh Rana, submitted on August 31, 2026. The resignation will take effect from September 06, 2026. Mr. Rana cited personal reasons for his departure and confirmed there are no other material reasons. The company will need to appoint a successor to manage financial oversight and reporting.
Confidence: HIGH
What changedMr. Avtar Singh Rana has stepped down as Chief Financial Officer of KRM Ayurveda Limited.
Why it mattersThe CFO position is critical for financial planning, statutory compliances, and reporting; timely appointment of a replacement is essential to maintain internal financial controls.
Resignation Intimation Date: August 31, 2026Effective Date of Cessation: September 06, 2026
📅 Short termInterim management transitions may temporarily affect finance department workflows until a permanent replacement is appointed.
📈 Long termLimited operational impact if a qualified successor is appointed promptly by the board.
⚠ Risk flags
- Key managerial personnel transition risk
- Interim vacancy in the CFO role until a successor takes charge
Key Highlights
CFO Mr. Avtar Singh Rana tendered resignation on August 31, 2026
Resignation effective date confirmed as September 06, 2026
Resignation tendered due to personal reasons with no other material reasons cited
👀 What to Watch
Watch for the board announcement regarding the appointment of a new Chief Financial Officer and ensure smooth continuity in financial reporting.
124.2% YoY PAT Growth in Q1 FY27; EBITDA Margins Expand to 38.22%
KRM Ayurveda reported a strong Q1 FY27 with total income rising 32.4% YoY to ₹32.87 cr. Net profit surged 124.2% YoY to ₹9.08 cr, driven by significant margin expansion with EBITDA margins reaching 38.22% (+1,257 bps YoY). The services segment (hospitals) was the primary driver, growing 109.8% YoY, while the company added 103 beds in FY27 YTD. Management expects these new beds to generate ₹25 cr in incremental annualised revenue.
Confidence: HIGH
What changedKRM Ayurveda has significantly improved its profitability profile through operating leverage and a shift toward higher-margin hospital services.
Why it mattersThe expansion into hospital services and the upcoming D2C launch represent a transition from a bulk-order product business to a more stable, high-margin healthcare services and consumer brand model.
Total Income (Q1 FY27): ₹3,286.55 LakhsNet Profit (Q1 FY27): ₹908.45 LakhsEBITDA Margin: 38.22%Beds Added (FY27 YTD): 103 unitsIncremental Revenue Potential: ₹25 cr
📅 Short termThe market is likely to react positively to the triple-digit PAT growth and the substantial expansion in operating margins.
📈 Long termStructural growth depends on the successful ramp-up of new hospital facilities (targeting 60-80% utilization) and the ability to leverage their 8 lakh+ digital audience for D2C sales.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Product business revenue declined significantly YoY (from ₹1,579 Lakhs to ~₹840 Lakhs)
- Execution risk in the new D2C platform launch
Key Highlights
Net Profit (PAT) increased 124.2% YoY to ₹908.45 Lakhs in Q1 FY27
EBITDA margins expanded by 1,257 bps YoY and 372 bps QoQ to 38.22%
Added 103 beds in FY27 YTD with an estimated annualised revenue potential of ₹25 cr
Services revenue grew 109.8% YoY to ₹2,392.20 Lakhs, offsetting a decline in product revenue
Digital reach includes 8 lakh+ YouTube followers to support the Q2 FY27 D2C platform launch
👀 What to Watch
Monitor the utilization rates of the 103 newly added beds and the execution of the D2C platform launch scheduled for Q2 FY27 to see if it stabilizes the product business revenue.
₹9.08 Cr Q1 PAT: KRM Ayurveda Net Profit Jumps 124% YoY on Strong Margin Expansion
KRM Ayurveda reported a robust performance for Q1 FY27, with revenue from operations growing 31% YoY to ₹32.32 crore. Net profit more than doubled to ₹9.08 crore from ₹4.05 crore in the year-ago period, driven by significant operating leverage as total expenses grew only 6.4% YoY. The company, listed on the NSE SME platform, voluntarily disclosed these quarterly results despite only being required to report half-yearly. Working capital remains strong at ₹81.27 crore, supported by ₹15.12 crore in unutilized IPO proceeds currently parked in fixed deposits.
Confidence: HIGH
What changedThe company has transitioned from half-yearly to voluntary quarterly reporting, delivering a significant earnings beat characterized by high profit growth relative to revenue.
Why it mattersThe results demonstrate strong operating leverage in the Ayurvedic medicine and therapy segment, where the company is managing to scale revenue without a proportional increase in employee or material costs.
Revenue (Q1 FY27): ₹32.32 crNet Profit (Q1 FY27): ₹9.08 crYoY Revenue Growth: 31.0%YoY PAT Growth: 124.2%Working Capital: ₹81.27 crUnutilized IPO Funds: ₹15.12 cr
📅 Short termThe stock is likely to see positive sentiment due to the sharp jump in profitability and the transparency shown through voluntary quarterly reporting.
📈 Long termThe company shows structural growth potential in the Ayurvedic sector; however, long-term value will depend on maintaining these high margins as they scale beyond their current base.
⚠ Risk flags
- SME segment liquidity risk
- Single business segment concentration (Ayurvedic medicines/therapies)
- Discrepancy in historical EPS data (₹270.19 vs ₹4.27) noted in the filing
Key Highlights
Revenue from operations increased 31% YoY to ₹32.32 crore from ₹24.67 crore.
Net profit surged 124% YoY to ₹9.08 crore, up from ₹4.05 crore in June 2025.
Profit Before Tax (PBT) margin improved to 37.2% in Q1 FY27 from 21.8% in Q1 FY26.
Total expenses were contained at ₹20.63 crore, representing a modest 6.4% increase despite the 31% revenue jump.
Unutilized IPO proceeds of ₹15.12 crore are currently held in earmarked fixed deposits for future expansion/needs.
👀 What to Watch
Investors should monitor the sustainability of the high 37% PBT margins and the deployment timeline for the ₹15.12 crore unutilized IPO funds into growth initiatives.
